ReviewEuropean radiology2026
Robot-assisted CT-guided interventions: Where are we now and where are we going?
Review in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesComputed tomography (CT)-guided interventions are central to interventional radiology (IR) but remain highly operator-dependent. Robotic assistance has been proposed to improve needle accuracy, reproducibility and radiation safety. While robotics are well established in surgery, their role in CT-guided IR remains evolving. This review synthesises current evidence, maps robotic CT-guided interventions onto the IDEAL framework for procedural innovation, and evaluates where these systems provide measurable clinical value. MATERIALS AND
methodsA narrative review was conducted according to established recommendations for high-quality narrative reviews and informed by SANRA principles. PubMed, Scopus and clinical trial registries were searched for studies evaluating robotic CT-guided percutaneous interventions. Evidence from preclinical, feasibility and comparative clinical studies was synthesised qualitatively and interpreted using the IDEAL framework.
resultsPreclinical studies consistently demonstrate improved targeting accuracy and fewer needle adjustments compared with freehand techniques. Clinical studies and systematic reviews support feasibility and safety across biopsy and ablation applications, with current clinical evidence concentrated in the liver, lung, kidney, and musculoskeletal system, particularly for long, oblique, and out-of-plane trajectories. Operator radiation exposure is frequently reduced, while procedure time and patient dose effects are variable. Most published studies correspond to IDEAL stages 1-2b, with emerging Stage 3 randomised evaluation; long-term and registry data remain limited.
conclusionRobot-assisted CT-guided interventions represent precision-enabling technologies but are not yet standard of care. Current evidence supports selective use in technically complex procedures. Wider adoption will depend on robust comparative studies, economic evaluation and structured implementation frameworks. KEY POINTS: Question What evidence supports robot-assisted CT-guided interventions in IR, and in which procedures do robotic systems provide clinical benefit? Findings Current clinical evidence is concentrated in liver, lung, kidney, and musculoskeletal interventions, demonstrating improved targeting precision and reduced needle adjustments and operator radiation exposure. Clinical relevance Robot-assisted CT-guided interventions may improve procedural precision and reduce radiation exposure in complex interventions, but wider adoption depends on stronger comparative evidence demonstrating meaningful clinical benefit, workflow efficiency, and cost-effectiveness.
Indexed as
Identifiers
42701129What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.